Parasitic lung diseases

Jaffar A Al-Tawfiq; Hojoong Kim; Ziad A Memish

doi:10.1183/16000617.0093-2022

Parasitic lung diseases

Eur Respir Rev. 2022 Nov 29;31(166):220093. doi: 10.1183/16000617.0093-2022. Print 2022 Dec 31.

Authors

Jaffar A Al-Tawfiq^{1

2

3}, Hojoong Kim⁴, Ziad A Memish^{5

6

7}

Affiliations

¹ Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
² Infectious Disease Unit, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
³ Infectious Disease Unit, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
⁴ Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁵ King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia zmemish@yahoo.com.
⁶ Department of Medicine, Al-Faisal University, Riyadh, Saudi Arabia.
⁷ Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Abstract

Parasitic lung diseases are caused by a number of parasites as a result of transient passage in the lung or as a result of an immunologic reaction. The clinical presentation may be in the form of focal or cystic lesions, pleural effusion or diffuse pulmonary infiltrates. With increasing globalisation, it is important to consider parasitic infections in the differential diagnosis of lung diseases. This is particularly important since early identification and prompt therapy result in full cure of these conditions. In this review, we summarise the most common parasitic lung diseases.

Publication types

Review

MeSH terms

Diagnosis, Differential
Humans
Lung Diseases, Parasitic* / diagnosis
Lung Diseases, Parasitic* / drug therapy
Pleural Effusion*
Thorax